ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,953Medicare Part D Prescriptions Filled, Including Refills

Rank: 299 out of 2456

$480K Total Retail Price of All Prescriptions

Rank: 247 out of 2456

465 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 465 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 465 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,728 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 817 708 1 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 391 334 2 41
LISINOPRIL 347 325 3 1
OMEPRAZOLE 306 221 4 3
METFORMIN HCL 267 237 5 11
AMLODIPINE BESYLATE 256 252 6 5
ZOLPIDEM TARTRATE 165 140 7 28
LEVOTHYROXINE SODIUM 164 122 8 4
FUROSEMIDE 162 139 9 8
METOPROLOL TARTRATE 148 140 10 10
WARFARIN SODIUM 137 125 11 9
SERTRALINE HCL 125 98 12 21
ATORVASTATIN CALCIUM 112 100 13 12
GLIMEPIRIDE 111 93 14 74
HYDROCHLOROTHIAZIDE 107 97 15 7
HYDROCODONE-ACETAMINOPHEN 106 103 S3 16 20
ALENDRONATE SODIUM 100 86 17 19
CRESTOR 90 72 18 25
GABAPENTIN 90 83 18 16
NIFEDIPINE ER 90 87 18 61
FLUTICASONE PROPIONATE 89 77 21 30
METOPROLOL SUCCINATE 83 79 22 13
PAROXETINE HCL 77 65 23 56
ATENOLOL 76 63 24 6
PRAVASTATIN SODIUM 76 43 24 15
TAMSULOSIN HCL 75 75 26 32
ALLOPURINOL 72 72 27 27
OXYCODONE HCL 68 25 S2 28 38
TRAMADOL HCL 67 47 29 24
PANTOPRAZOLE SODIUM 66 64 30 37
AMLODIPINE BESYLATE-BENAZEPRIL 63 50 31 144
CLOTRIMAZOLE-BETAMETHASONE 63 53 31 182
NAPROXEN 62 47 33 109
CELEBREX 57 50 34 127
NABUMETONE 54 41 35 164
POLYETHYLENE GLYCOL 3350 52 44 36 64
MELOXICAM 51 37 37 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 27, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.